Canada
· Delayed Price · Currency is CAD Theralase Technologies Statistics
Total Valuation
TSXV:TLT has a market cap or net worth of CAD 64.42 million. The enterprise value is 64.41 million.
| Market Cap | 64.42M |
| Enterprise Value | 64.41M |
Important Dates
The next estimated earnings date is Thursday, March 27, 2025.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:TLT has 247.78 million shares outstanding. The number of shares has increased by 7.23% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 247.78M |
| Shares Change (YoY) | +7.23% |
| Shares Change (QoQ) | +1.18% |
| Owned by Insiders (%) | 6.85% |
| Owned by Institutions (%) | 0.17% |
| Float | 230.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 61.29 |
| PB Ratio | 29.85 |
| P/TBV Ratio | 30.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.88 |
| EV / Sales | 65.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.56 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.91 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | -169.50 |
Financial Efficiency
Return on equity (ROE) is -229.60% and return on invested capital (ROIC) is -121.27%.
| Return on Equity (ROE) | -229.60% |
| Return on Assets (ROA) | -87.66% |
| Return on Invested Capital (ROIC) | -121.27% |
| Return on Capital Employed (ROCE) | -185.00% |
| Revenue Per Employee | 49,330 |
| Profits Per Employee | -216,451 |
| Employee Count | 20 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 0.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.50% in the last 52 weeks. The beta is 1.17, so TSXV:TLT's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +62.50% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 46.34 |
| Average Volume (20 Days) | 93,313 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:TLT had revenue of CAD 986,596 and -4.33 million in losses. Loss per share was -0.02.
| Revenue | 986,596 |
| Gross Profit | 510,169 |
| Operating Income | -4.36M |
| Pretax Income | -4.33M |
| Net Income | -4.33M |
| EBITDA | -4.18M |
| EBIT | -4.36M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 329,504 in cash and 317,733 in debt, giving a net cash position of 11,771 or 0.00 per share.
| Cash & Cash Equivalents | 329,504 |
| Total Debt | 317,733 |
| Net Cash | 11,771 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 2.14M |
| Book Value Per Share | 0.01 |
| Working Capital | 788,440 |
Cash Flow
In the last 12 months, operating cash flow was -4.12 million and capital expenditures -24,484, giving a free cash flow of -4.14 million.
| Operating Cash Flow | -4.12M |
| Capital Expenditures | -24,484 |
| Free Cash Flow | -4.14M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | 51.71% |
| Operating Margin | -442.29% |
| Pretax Margin | -438.78% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:TLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.23% |
| Shareholder Yield | -7.23% |
| Earnings Yield | -6.72% |
| FCF Yield | -6.43% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:TLT has an Altman Z-Score of -8.92. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.92 |
| Piotroski F-Score | n/a |